MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
English
Profile: MII PR Onkologie Tumorkonferenz version: 2027.0.0-ballot.1
status: Active
intent: Plan
category: Molekulares Tumorboard
subject: Erika Beispiel Female, DoB: 1965-04-12
created: 2024-01-15
addresses: Condition Bösartige Neubildung: Brustdrüse, nicht näher bezeichnet
activity
Details
Code Status Description Zielgerichtete Anti-HER2 Therapie Not Started Basierend auf HER2-Amplifikation: Trastuzumab + Pertuzumab Kombination empfohlen
activity
Details
Code Status Description Chemotherapie + CDK4/6 Inhibitor Not Started Alternative basierend auf HR+/HER2- Status: Palbociclib + Letrozol
activity
Details
Code Status Description Strahlentherapie Not Started Adjuvante Bestrahlung nach Operation